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Bronchiolitis is the leading cause of infant
hospitalization in the United States, and its
hospitalization rates have more than doubled
in the last two decades (Leader and Kohlhase
2002; Shay et al. 1999). It has been reported
that 40–50% of children diagnosed with
bronchiolitis suffer from subsequent wheez-
ing and airway reactivity or asthma (Hall
2001). Children with underlying heart or
lung disease may have a very severe disease
course (Aujard and Fauroux 2002).
The evidence is relatively strong that envi-
ronmental tobacco smoke and possibly
indoor exposure to wood smoke are risk fac-
tors for bronchiolitis (Aujard and Fauroux
2002; Robin et al. 1996). On the other hand,
data on the impact of ambient air pollution
on bronchiolitis are scarce.
Respiratory syncytial virus (RSV) infection
accounts for up to 90% of the bronchiolitis
cases that occur in infancy (Domachowske
and Rosenberg 1999; Hall 2001). Thus, we
are operating under the theoretical paradigm
that virus-induced proinﬂammatory mediators
and innate immune responses are modified
by pollution in such a way that a more severe
outcome (i.e., symptoms requiring hospitaliza-
tion) ensues. Based on the usual time course of
RSV symptom development, it seemed
appropriate to consider lags from 1 to 9 days
(Figure 1).
Few animal toxicologic studies of joint
exposure to respiratory viruses and ambient
air pollutants are available. Those that are
available model primarily exposure to pollu-
tants soon after infection, during the incuba-
tion phase, and demonstrate potentiation of
the disease process (Becker and Soukup 1999;
Harrod et al. 2003; Lambert et al. 2003).
Epidemiologic studies of childhood asthma
exacerbation by air pollution exposure exam-
ined a variety of acute windows of exposure
and found several exposure periods/lags
important for adverse events ranging from 0
to 5 days (Gouveia and Fletcher 2000; Lee
et al. 2002; Romieu et al. 1995; Sunyer et al.
1997).
In the following, we relied on data from
the South Coast Air Basin (SoCAB) of south-
ern California [California Environmental
Protection Agency (EPA) 2002; California
Health and Human Services Agency 2003]
and a case–crossover design to determine
a) whether short-term increases in ambient
air pollution are related to increased bronchi-
olitis hospitalization risk in infants; b) what
the impacts are of different types of winter-
time ambient air pollution, including fine
particulate matter (PM2.5, ≤ 2.5 µm in aero-
dynamic diameter) and gaseous pollutants
(nitrogen dioxide and carbon monoxide); and
c) whether risks differ for potentially more
susceptible subgroups of infants such as pre-
mature infants and those with underlying
lung or heart disease.
Materials and Methods
Subjects. Cases were all children born in
SoCAB during the years 1995–2000, drawn
from a data set created by the California
Office of Statewide Health Planning and
Development (California Health and Human
Services Agency 2003) that linked birth
records and ﬁrst year of life hospital discharge
records and included all in-hospital births
(excluding birthing centers, home births, and
military facilities). Approval for access to
these data was provided by the California
Committee for the Protection of Human
Subjects and the University of Washington
Human Subjects Division.
The SoCAB includes California’s largest
metropolitan region, covering the southern two
thirds of Los Angeles County, all of Orange
County, and the western urbanized portions of
Riverside and San Bernadino counties. This
densely populated region is home to > 40% of
the state’s population and generates about 30%
of the state’s total criteria pollutant emissions
(California Air Resource Board 2001).
We identiﬁed all infants with record of a
single hospitalization in the first year of life
with a discharge diagnosis of acute bronchi-
olitis [International Classification of Diseases,
9th Revision, CM466.1 (World Health
Organization 1978)] and a birth residence in
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We examined the association of infant bronchiolitis with acute exposure to ambient air pollutants.
DESIGN: We employed a time-stratiﬁed case–crossover method and based the exposure windows on
a priori, biologically based hypotheses.
PARTICIPANTS: We evaluated effects in 19,901 infants in the South Coast Air Basin of California in
1995–2000 with a hospital discharge record for bronchiolitis in the ﬁrst year of life (International
Classiﬁcation of Diseases, 9th Revision, CM466.1).
EVALUATIONS/MEASUREMENTS: Study subjects’ ZIP code was linked to ambient air pollution moni-
tors to derive exposures. We estimated the risk of bronchiolitis hospitalization associated with
increases in wintertime ambient air pollutants using conditional logistic regression.
RESULTS: We observed no increased risk after acute exposure to particulate matter ≤ 2.5 µm in
aerodynamic diameter (PM2.5), carbon monoxide, or nitrogen dioxide. PM2.5 exposure models sug-
gested a 26–41% increased risk in the most premature infants born at gestational ages between
25 and 29 weeks; however, these ﬁndings were based on very small numbers.
CONCLUSIONS: We found little support for a link between acute increases in ambient air pollution
and infant bronchiolitis except modestly increased risk for PM2.5 exposure among infants born very
prematurely. In these infants, the periods of viral acquisition and incubation concurred with the
time of increased risk.
RELEVANCE TO PROFESSIONAL PRACTICE: We present novel data for the infant period and the key
respiratory disease of infancy, bronchiolitis. Incompletely explained trends in rising bronchiolitis
hospitalization rates and increasing number of infants born prematurely underscore the importance
of evaluating the impact of ambient air pollution in this age group in other populations and studies.
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ent air pollution monitor. We further
restricted the population of infants to all hos-
pitalization during the annual RSV epidemic
season (November–March) who were hospi-
talized after 3 weeks of age. The goal of the
later restriction was to increase the likelihood
that the infant was released from the hospital
after birth and exposed to air pollution at its
home.
Exposure assessment. We extracted air pol-
lutant monitoring data for 1995–2000 from
the electronic database of the California
Environmental Protection Agency Air
Resources Board (California EPA 2002).
During this period, several air monitoring sta-
tions provided data for the U.S. EPA criteria
air pollutants of interest CO (36 monitors) and
NO2 (34 monitors), and in 1999, 17 monitor-
ing stations started collecting data for PM2.5.
For each subject, exposure assessment was
based on the hospitalization residential ZIP
code that was assigned to the most representa-
tive ambient monitor based on proximity,
topography, and prevailing wind conditions
(for more details, see Ritz et al. 2002). Daily
mean temperature and humidity data came
from the National Weather Service and the
U.S. EPA Aerometric Information Retrieval
System (National Weather Service 2004; U.S.
EPA 2004). We mapped infants residential ZIP
code centroids to the nearest weather monitor.
We investigated exposure windows
selected a priori according to biologically plau-
sible mechanisms. These reﬂected the tempo-
ral sequence of pathophysiologic events in
bronchiolitis infection, some animal toxicol-
ogy data, and lags previously employed in
studies of childhood asthma. Thus, we evalu-
ated lags that were likely to represent the over-
lap of pollutant exposure with distinct biologic
processes—for example, rapid viral replication
and incubation (lags of 1 and 4 days; Figure
1). We also tested an additional exposure
window for PM2.5, that is, the period that
overlaps with initial viral infection (lag of
6–8 days), because this was the pollutant of
primary interest based on relatively greater evi-
dence from the toxicologic and epidemiologic
literature.
Data analysis. We employed a case–
crossover design to compare exposure of cases
just before a health event (“index”) with their
exposure sampled from some separate “refer-
ent” time period(s) (Levy et al. 2001; Lin et al.
2003; Neas et al. 1999). Thus, cases serve as
their own controls, providing implicit control
of all known and unknown confounders that
are unlikely to vary nonrandomly during the
index and referent time periods—for example,
socioeconomic factors, environmental tobacco
smoke, and household crowding. In addition,
we used a time-stratified approach in which
strata were deﬁned as the days of week in each
calendar month of each year of the study
period (1995–2000), or for PM2.5, as the days
for which sampling data were available in each
calendar month of the study period (i.e., 3-day
intervals for 1999–2000).
The speciﬁc index periods of interest were
24-hr CO measures and 1-hr maximum NO2
measures lagged by 1 and 4 days. The CO and
NO2 referent exposures are all other daily (aver-
age) measures for that pollutant that fell in the
same month of the same year and on the same
days of week as the index period. For PM,
index exposures represent 1–2 days, 3–5 days,
or 6–8 days before the hospitalization event.
The PM2.5 referent exposures are the mean
daily measures of all nonindex sampling days
of the month and year that were separated by
6-day increments from the index day.
Employing conditional logistic regression,
we estimated the relative risk of hospitalization
for bronchiolitis per interquartile increase
in gaseous air pollutants and per 10-µg/m3
increase in PM2.5; the scale for particles
ensures comparability with previous air pollu-
tion studies.
Day of the week (in particulate analysis)
and daily mean temperature and humidity (in
all analyses) were entered into the models to
control for potential confounding due to
these time-varying factors. Lags for tempera-
ture and humidity paralleled the modeled air
pollution lags.
We considered the potential for differen-
tial susceptibility within subgroups in strati-
fied analyses; that is, a primary interest was
to assess differences in effects for premature
infants (born before gestational week 37) and
infants with underlying cardiopulmonary dis-
ease. Gestational age was determined from
birth records, and cardiopulmonary disease
from both birth records and first year of life
hospitalization records.
Results
Study subjects. A total of 19,109 infants met
the case deﬁnition of a single hospitalization
for bronchiolitis with an admission month of
November through April at 3 weeks to 1 year
of age. Descriptive characteristics of these
subjects are provided in Table 1.
Study subjects were more often male
(60%) and most were hospitalized within
the ﬁrst 6 months of life (73%). Mean age at
admission was 4.7 months. Although pre-
maturity is a well-known risk factor and pre-
maturely born infants were at higher risk, most
infants affected were born at (or near) term
(84% of subjects). Most subjects (65%) were
of Hispanic ethnicity. Medicaid was the pay-
ment source for bronchiolitis hospitalization
for 61% of infants, whereas some type of pri-
vate insurance coverage was indicated for 35%.
The remainder listed other sources including
other governmental programs, charity care,
self-pay, and no charge.
Abnormal conditions affecting the heart
or lungs in the newborn period—including
Karr et al.
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Figure 1. Time course of viral and clinical events in RSV infection and lags (exposure windows) investigated.
Days
Clinical
disease
event
Time (days)
Viral
disease
event
Initial infection Incubation Replication Peak Decline
Lag 3, 4, 5, 6, 7, 8 Lag 1, 2 Lag 0
Symptoms
start
Symptoms peak
(potential
hospital
admission)
Symptoms decline
0 1 2 3 4 5 6 7 8 9 10 11 12
Table 1. Characteristics of infants hospitalized for
bronchiolitis (cases) (n = 19,109).a
Variable No. (%)
Age at admission (days)
21–90 8,168 (42.7)
91–180 5,819 (30.5)
181–270 3,196 (16.7)
271–365 1,926 (10.1)
Gestation (weeks)
37 1/7–44 16,049 (84.0)
34 1/7–37 2,035 (10.7)
29 1/7–34 789 (4.1)
25–29 236 (1.2)
Sex
Male 11,277 (59.7)
Female 7,832 (40.3)
Ethnicity
Hispanic 12,373 (64.8)
Non-Hispanic 6,393 (33.5)
Unknown 343 (1.7)
Recorded respiratory/
cardiac conditions of newborn
Respiratory distress syndrome 609 (3.2)
Bronchopulmonary dysplasia 85 (0.4)
Pulmonary anomalies 63 (0.3)
Any pulmonary disease 678 (3.6)
Cardiac anomalies 505 (2.6)
Payment source
MediCal 11,673 (61.1)
Private insurance/HMO/PPO 6,670 (34.9)
Other 766 (4.0)
Abbreviations: HMO, health maintenance organization;
PPO, preferred provider organization.
aIncludes infants meeting study case deﬁnition of hospital-
ized once at 3 weeks to 1 year of age with admission date
in period November–April for 1995–2000.respiratory distress syndrome, bronchopul-
monary dysplasia, pulmonary anomalies (e.g.,
congenital diaphragmatic hernia), and con-
genital cardiac anomalies—were rare: Birth
certificate and birth hospitalization data
reported 609 subjects (3.2%) with respiratory
distress syndrome, 85 (0.4%) with bron-
chopulmonary dysplasia, 63 (0.3%) with pul-
monary anomalies, and 505 (2.6%) with
identiﬁable cardiac anomalies.
Air pollution and meteorologic data. The
distributions of daily 24-hr average CO,
PM2.5, and daily 1-hr maximum NO2 for
subjects during index and referent periods are
summarized in Table 2. The mean CO at a
lag of 1 or 4 days was 1,730 and 1,760 ppb
on index days and 1,750 and 1,790 ppb on
referent days, respectively. Mean NO2 at a lag
of 1 or 4 days was 59 ppb on index days and
60 ppb on referent days. Mean PM2.5
(µg/m3) during index days at lags 1–2, 3–5,
or 6–8 days was 23.3, 23.9, and 23.6 ppb; on
referent days it was 23.7, 24.1, and 24.1 ppb,
respectively.
The mean distance between study sub-
jects’ residential ZIP code centroid and their
representative PM2.5, CO, NO2, and meteo-
rologic monitor was approximately 4–5 miles,
and although 90% of subjects lived within
11 miles, the maximum distance was 25 miles.
The sample size for the PM2.5 analyses
was smaller than for the CO and NO2 analy-
ses because the former data were available
only for the last 2 years (7,821 cases identiﬁed
occurred in when PM2.5 data were available).
Approximately 20% of all cases were missing
pollutant data for lags of interest. Linkage
to weather monitors was unsuccessful for
roughly 9%, further decreasing the sample
when controlling for these factors. Linkage of
ZIP codes to weather monitors was based on
current ZIP codes, and some of the ZIP codes
or ZIP code boundaries had changed since
the years of study (1995–2000).
Because of missing data for gaseous pollu-
tants monitored on a daily basis, approximately
4–5% of subjects were dropped because of
missing CO data, and 9% for missing NO2
data. In addition, linkage to weather monitors
was unsuccessful for roughly 5,000 subjects
(25%) in each analysis.
Associations between a 10-µg/m3 increase
in PM2.5 and bronchiolitis hospitalization.
Increases in PM2.5 (per 10 µg/m3) for the three
lag periods investigated were not associated
with risk of bronchiolitis hospitalization; in
fact, exposure was marginally protective in
some cases (Table 3).
Analyses stratified on categories of pre-
maturity (25–29 weeks, 29 1/7–34 weeks,
34 1/7–37 weeks, and 37 1/7–44 weeks) sug-
gested elevated risk for the most premature
infants for all exposure lags > 2 days, with a
26% (1.01–1.57) estimated risk increase for
day 3, 4, 5 lags for infants born at 25–29
weeks gestation, and a 41% (1.11–1.79)
increase for day 6, 7, 8 lags. No dose response
was observed with increasing gestational age
(Table 3).
We did not observe effects for infants with
respiratory distress syndrome, underlying pul-
monary disease, or cardiac anomalies (Table
3); rather, we again observed some reduced
risks in this subgroup.
Associations between an interquartile
range increase in the gaseous pollutants CO,
NO2, and bronchiolitis hospitalization. We
did not observe increased risk of bronchiolitis
hospitalization per interquartile range (IQR)
increases in 24-hr average CO 1 or 4 days
before admission (Table 4). Overall odds ratio
(OR) estimates for lags of 1 and 4 days were
0.99 (0.96–1.02) and 0.97 (0.94–1.00),
respectively. Analyses stratified on prematu-
rity categories and infants with respiratory or
cardiac conditions also yielded null results
(Table 4).
Similarly, we found that increases per IQR
in 1-hr daily maximum NO2 1 or 4 days before
admission were not associated with increased
risk of bronchiolitis hospitalization (Table 4); in
fact, they also seemed marginally protective.
Overall ORs for lags of 1 and 4 days were 0.97
(0.95–0.99) and 0.96 (0.94–0.99), respectively.
In addition, we found no indication for effect
modiﬁcation when stratifying by prematurity
and infants with heart and lung conditions.
Discussion
Evaluating the inﬂuence of short-term increases
in CO, NO2, and PM2.5 on infant bronchiolitis
hospitalization, we did not ﬁnd support for the
hypothesis that hospitalization for bronchiolitis
might be positively associated with exposure to
ambient air pollution. We chose lag periods
that corresponded to exposure occurring during
Case–crossover study of infant bronchiolitis
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Table 2. Distribution of daily air pollution measures on index and referent days in case–crossover study of
ambient air pollutants.a
Percentile
No. Lag Minimum 25th 50th 75th 90th Maximum Mean
1-hr maximum
NO2 (ppb)
Index 17,318 1 6 43 53 69 90 243 59
Referent 58,155 1 1 43 54 70 92 250 60
Index 17,328 4 6 43 54 70 91 250 59
Referent 58,178 4 2 43 54 71 93 243 60
24-hr daily average
CO (ppb)
Index 18,260 1 4 930 1,520 2,260 3,160 9,600 1,730
Referent 61,128 1 4 920 1,510 2,290 3,230 9,600 1,750
Index 18,245 4 4 930 1,540 2,310 3,230 8,710 1,760
Referent 61,099 4 4 940 1,550 2,350 3,300 9,600 1,790
24-hr daily average
PM2.5 (µg/m3)
Index 4,960 1 or 2 1.5 12.7 19.8 30.7 42.0 99.0 23.3
Referent 16,424 1 or 2 1.5 13.1 20.2 30.5 42.3 121.4 23.7
Index 6,220 3, 4, or 5 1.5 12.9 20.3 31.6 42.0 99.0 23.9
Referent 26,684 3, 4, or 5 1.5 13.2 20.5 31.7 44.1 121.4 24.1
Index 6,106 6, 7, or 8 2.2 12.9 20.1 31.0 42.2 99.0 23.6
Referent 20,031 6, 7, or 8 1.5 13.0 20.5 32.0 44.3 121.4 24.1
aIndex days are days lagged in reference to date of hospitalization of a case. Referent days for each case include all days
that are the same day of week and in the same month as the index day for that case for CO and NO2. For PM2.5, referent days
for each case include all days separated by 6-day intervals from the index day in the index month.
Table 3. ORs (95% CIs) for bronchiolitis hospitalization with a 10-µg/m3 increase in PM2.5 lagged 1–2, 3–5,
or 6–8a days according to potentially modifying factors.
1–2 Days 3–5 Days 6–8 Days
Subjects No. OR (95% CI)b No. OR (95% CI)b No. OR (95% CI)b
Overall 4,353 0.96 (0.94–0.99) 5,444 0.98 (0.96–1.00) 5,319 0.96 (0.93–0.98)
Gestation (weeks)
37 1/7–44 3,682 0.96 (0.94–0.99) 4,593 0.98 (0.96–1.01) 4,485 0.95 (0.93–0.98)
34 1/7–37 449 0.97 (0.89–1.06) 567 0.95 (0.88–1.02) 549 0.96 (0.89–1.03)
29 1/7–34 176 0.96 (0.83–1.11) 223 0.95 (0.85–1.08) 218 0.99 (0.88–1.11)
25–29 46 0.98 (0.75–1.29) 61 1.26 (1.01–1.57) 67 1.41 (1.11–1.79)
Respiratory distress syndrome 112 0.77 (0.63–0.94) 142 0.96 (0.82–1.12) 144 1.05 (0.90–1.23)
Bronchopulmonary dysplasia 16 0.77 (0.46–1.28) 17 0.94 (0.64–1.39) 16 1.13 (0.77–1.65)
Pulmonary anomalies 16 0.95 (0.64–1.43) 20 0.95 (0.68–1.33) 19 1.09 (0.76–1.56)
Any pulmonary disease 127 0.82 (0.69–0.98) 164 0.94 (0.82–1.09) 164 1.05 (0.91–1.21)
Cardiac anomalies 117 0.89 (0.75–1.05) 153 0.98 (0.85–1.13) 152 0.87 (0.75–1.00)
aPM2.5 data are typically measured every third day, so each infant potentially has information on exposure lagged by 0, 3,
6 days, or 1, 4, 7 days, or 2, 5, 8 days, depending on the relationship of their hospitalization to the monitoring schedule. We
excluded 1-day lags. bAdjusted for day of week, mean daily temperature, and mean daily humidity.the most likely times of virus acquisition,
incubation, and replication/initial clinical
recognition.
There are no published reports based on
U.S. data for infant bronchiolitis hospitaliza-
tion and the air pollutants we investigated.
However, two European studies addressed
chronic exposure to “traffic” and respiratory
outcomes including infant bronchiolitis. Most
comparable with our study may be a recently
published prospective cohort study of Chilean
infants aged 4 months to 1 year that focused
on “wheezy bronchitis” (a term not commonly
used in the United States but that describes a
clinical entity similar to what is termed bron-
chiolitis in U.S. infants) and acute exposure to
ambient air pollution (Pino et al. 2004). The
authors estimated modestly increased risks
related to PM2.5 exposure; for each 10-µg/m3
increase of PM2.5 lagged by 1 day, the risk for
receiving a diagnosis of wheezy bronchitis
increased by 5% [95% confidence interval
(CI), 0–9%]. No consistent associations were
detected with NO2 levels. An Italian study
reported increased risks of bronchiolitis diag-
nosis in the ﬁrst 2 years of life when parents
reported lorry trafﬁc “sometimes” (OR = 1.52;
95% CI, 1.05–2.18) or “often” near their resi-
dence (OR = 1.74; 95% CI, 1.09–2.77) com-
pared with those who reported never lorry
traffic (Ciccone et al. 1998). A cohort study
conducted in the Netherlands examining
modeled exposure to trafﬁc-related pollutants
(Brauer et al. 2002) found a statistically signif-
icant increase in doctor-diagnosed asthma dur-
ing the ﬁrst year of life (reported by parents)
for an interquartile increase in PM2.5 and soot
but not NO2. Given the clinical similarity of
asthma and bronchiolitis in the first year of
life, it is possible that some if not all of these
“asthma” diagnoses in the ﬁrst year of life were
in fact cases of bronchiolitis. Albeit limited,
these studies suggest that some aspect of ambi-
ent particulate air pollution may adversely
affect bronchiolitis occurrences.
In recent years, there has been a focus on
evaluating speciﬁc age groups and individuals
with underlying health conditions, in an effort
to identify potentially vulnerable subpopula-
tions. In this study, we observed an increased
risk only for the most extremely premature
infants (25–29 weeks gestation) exposed to
PM2.5 at a lag of 3–5 days or 6–8 days. It is
important to interpret these modest positive
associations in the general context of a) a lack
of increase in risk for infants overall and for
other subgroups we considered; b) the rela-
tively small sample size these associations are
based on; c) the lack of this observation in
analyses of CO and NO2, pollutants corre-
lated in the atmosphere with PM2.5, that
included a larger number of subjects; and
d) the lack of a dose–response relationship
with gestational age. Although they support
the hypothesis that infants with premature
lung development are predisposed to chronic
lung disease and may experience more severe
impacts from respiratory infections when
exposed in addition to ambient air pollution,
no data to date in the medical/scientiﬁc litera-
ture support these ﬁndings.
We found no increased risk for infants
with underlying cardiac or pulmonary disease.
Indeed, we observed marginally statistically
significant protective effects for some of the
pollutant-speciﬁc exposure windows and sub-
groups. The protective effects varied by pollu-
tant and lag and demonstrated no patterns or
common mechanisms. The reliability of this
aspect of our study is suspect. Based on the
number of infants born at each gestational age
category in this study, approximately 1,400
cases of respiratory distress syndrome would
be expected, whereas in these data fewer than
half that many infants were coded as such.
This limited the power and credibility of
addressing this potentially vulnerable sub-
group. We suspect similar problems for iden-
tifying infants with other pulmonary and
cardiac conditions.
Overall, our findings were largely null.
Possible explanations include the lack of any
true association, lack of power to identify very
small effects, nondifferential misclassiﬁcation
of exposure, and our failure to address the bio-
logically most relevant window of exposure.
In our study, CO levels were relatively
high for U.S. standards and not unlike those
observed in studies reporting positive associa-
tions with asthma exacerbations and infant
respiratory mortality. The region studied
includes Los Angeles County, which has been
designated a “nonattainment area” based on
exceedance of the national regulatory standard
for CO. The highest concentrations of CO are
generally associated with cold, stagnant
weather conditions that occur during the win-
ter, which is also the peak time of bronchioli-
tis. Particulate exposures in this study were
also relatively high by U.S. standards. The lev-
els observed are similar to those described in
studies demonstrating adverse effects on infant
respiratory disease, such as the Netherlands
cohort described above and a U.S. infant res-
piratory mortality study (Woodruff et al.
1997). The Chilean infant cohort study
described above, however, experienced consid-
erably higher levels of ﬁne particulate (mean
24-hr levels of 52 µg/m3 vs. 24 µg/m3 in this
study) and identiﬁed infants with outpatient
illness rather than hospitalizations (Pino et al.
2004). NO2 levels observed in this study did
not exceed U.S. regulatory levels but were rela-
tively high by national standards.
Regarding the windows of exposure inves-
tigated, we made an effort to remain within
the framework of the a priori hypothesis as
stated, to the extent that acute windows of
interest related to our literature review on
pediatric asthma. However, this literature
may be too limited, especially for gaseous pol-
lutants, and we may have missed more rele-
vant windows. In addition, the case–crossover
design employed here is, by design, an acute
exposure model only. It precludes addressing
longer lags as well as chronic or subchronic
exposure that may inﬂuence an infant’s lung
response to subsequent RSV infection and the
development of bronchiolitis severe enough
to warrant hospitalization in the U.S. system.
The extent to which nondifferential mis-
classiﬁcation of exposure biased the estimates
toward the null in these data is not known.
The use of ambient air pollutant monitors to
create personal exposure measures relying on
residential ZIP codes linked to a “represen-
tative” monitor provides opportunity for
such misclassification. Exposure misclassi-
ﬁcation may vary by pollutant, monitor siting,
and regional and individual factors such as
mobility.
The current literature suggests that using
ambient monitors as proxies for PM2.5, which
is more homogeneously dispersed over large
Karr et al.
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Table 4. ORs (95% CIs) for bronchiolitis hospitalization with an IQR increase in daily 24-hr average CO or daily
maximum 1-hr NO2 lagged 1 day or lagged 4 days, according to gestational age (single-pollutant model).
Lag 1 day Lag 4 day
No. OR (95% CI)a No. OR (95% CI)a
CO
Overall 14,177 0.99 (0.96–1.02) 14,150 0.97 (0.94–1.00)
Gestation (weeks)
37 1/7–44 11,924 1.00 (0.97–1.03) 11,881 0.97 (0.94–1.00)
34 1/7–37 1,474 0.95 (0.87–1.04) 1,498 0.98 (0.90–1.08)
29 1/7–34 606 1.00 (0.86–1.15) 598 0.89 (0.77–1.03)
25–29 173 0.86 (0.68–1.10) 173 0.93 (0.72–1.20)
NO2
Overall 13,619 0.97 (0.95–0.99) 13,617 0.96 (0.94–0.99)
Gestation (weeks)
37 1/7–44 11,471 0.98 (0.95–1.00) 11,441 0.97 (0.94–0.99)
34 1/7–37 1,401 0.90 (0.84–0.97) 1,427 0.94 (0.88–1.02)
29 1/7–34 586 1.01 (0.91–1.13) 586 0.90 (0.80–1.01)
25–29 161 0.94 (0.78–1.13) 163 0.90 (0.73–1.11)
For CO, 1-day lag IQR = 1,361 ppb; 4-day lag IQR = 1,400 ppb. For NO2, 1-day lag IQR = 27 ppb; 4-day lag IQR = 28 ppb.
aAdjusted for mean daily temperature and humidity.areas, would likely result in less misclassiﬁca-
tion compared with the other pollutants we
examined (Oglesby et al. 2000; Sarnat et al.
2001). Nonetheless, the fraction of outdoor-
generated particulate (or other pollutants)
that penetrates indoors is a function of hous-
ing characteristics, including air exchange
rates, building surface-to-volume ratio, use of
air conditioning, and use of windows for ven-
tilation, and therefore misclassiﬁcation occurs
to some extent for PM2.5 as well.
The siting characteristics of the monitors
employed in this study and described by the
California Air Resources Board (2005) state
that all of the PM2.5 monitors represent neigh-
borhood-scale exposures (in the 2- to 3-mile
range), somewhat less than the average distance
of our subject’s assigned monitor (4–5 miles).
Approximately one-third of the CO and NO2
monitors represented much smaller scales, and
thus we may have introduced more exposure
misclassiﬁcation by extrapolating farther from
these stations. A proportion of the NO2 (24%)
monitors were felt to represent a larger scale
(up to 30 miles), diminishing spatial variabil-
ity. To address exposure misclassiﬁcation due
to local heterogeneity, we conducted a sensitiv-
ity analysis in which we used only data from
infants living within 5 miles or 2 miles of a
monitoring station (data not shown). In addi-
tion, a sensitivity analysis excluding subjects
with exposure from monitors in the microscale
and middle-scale range (< 0.3 miles) was per-
formed. This applied only to the NO2 and CO
monitors, not PM2.5 monitors. With these
restricted samples of more proximal or repre-
sentative monitors, point estimates were not
meaningfully altered, and all CIs widened
because of loss of subjects.
Last, if the ZIP code was inaccurate or an
infant spent a large proportion of time in an
area with a different representative monitor
(child care, joint custody), additional exposure
misclassiﬁcation would have occurred. Because
we modeled exposures relatively close to time
of hospitalization (within 1 month) and the
hospitalization record of a child’s residential
ZIP code was used for exposure assessment,
misclassiﬁcation due to subjects’ moving is less
likely.
Although most of our analyses yielded
null ﬁndings, several estimates were “protec-
tive”—that is, in the opposite direction of our
expectation. One explanation is that it is a
chance ﬁnding; other explanations are that we
inadequately addressed confounding or that
our results reflect some systematic bias. We
did a number of sensitivity analyses including
restricting analyses to Los Angeles County
infants only, stratifying by age of diagnosis,
and stratifying by parity of mother, the latter
as a proxy of household crowding. None of
these analyses yielded ﬁndings that meaning-
fully modified the results presented here or
changed the interpretation.
We presented results from a novel study of
short-term air pollution effects, focusing atten-
tion on the infant period and the disease bron-
chiolitis. It will be important to evaluate the
impact of ambient air pollution in this age
group in other populations and studies.
Hospitalization rates for bronchiolitis appear
to be increasing over the last two decades, as
are the proportion of infants surviving pre-
mature birth. Thus, the importance of assur-
ing that air quality regulations are protective
for this potentially vulnerable subgroup is
underscored. Attention to improved exposure
assessment that can include adequate identiﬁ-
cation and numbers of potentially especially
vulnerable infants (e.g., prematurely born,
with underlying heart and lung conditions)
will be important in more clearly deﬁning the
role of air pollution in infant bronchiolitis.
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